1. Treatment Options for Post-MI patients with LVD – are all ACE Inhibitors Equal?

2. Program Overview

3. Influence of LV Dysfunction on Post-MI Outcomes

4. Predictive Value of Markers of Organ Damage

5. Treatment Options: Targeting Neurohormonal Pathways

6. ESC Guideline Recommendations

7. Distinguishing Between Agents in the Same Class: Considerations

8. Class Effect: ACE Inhibitors Post-MI

9. SMILE: Overview

10. SMILE: Rationale

11. Cardioprotective Effects of Zofenopril

12. Effects of ACE Inhibitors on Endothelial Stress

13. SMILE-4: Distinguishing Between ACE Inhibitors in Combination With Aspirin

14. SMILE-4: Subanalysis in Hypertensive Patients

15. SMILE-ISCHEMIA: Analysis of Patients With Preserved LV Function

16. Conclusions

17. Abbreviations

18. Abbreviations